Clinically reviewed by Dr. Mary Beth Augustine, DCN, RDN, FAND

Wheat-related disorders are often associated with digestive distress, autoimmune conditions, and chronic inflammation.  

However, emerging research suggests they may also contribute to broader health concerns, including cardiovascular risk. Understanding how wheat-related immune responses affect lipid profiles could provide valuable insights for both clinicians and patients. 

A Vibrant lab team study published in Biomarkers examined the lipid profiles and nutritional status of individuals with wheat-related disorders. The findings reveal potential links between wheat immune reactivity and key cardiovascular risk factors.  

Additionally, recent research published in Nutrients and The Journal of Clinical Endocrinology & Metabolism supports these findings, indicating that chronic low-grade inflammation from wheat-related disorders may contribute to endothelial dysfunction and metabolic syndrome. 

Table of Contents

Study Overview  

Researchers analyzed data from 1,041 individuals experiencing wheat-related symptoms. Participants underwent serological testing for wheat protein antibodies using the Wheat Zoomer and Celiac Disease panels. Those with positive results were further assessed for lipid profiles and micronutrient levels to explore potential metabolic implications. 

Key Findings: Lipid Imbalances in Wheat-Reactive Individuals  

The study revealed notable disruptions in lipid metabolism among individuals with wheat-related immune responses: ¹

• Lower HDL Levels: Subjects who had positive antibody results on the Wheat Zoomer panel or positive antibody results on the Celiac Disease panel showed significantly reduced high-density lipoprotein (HDL) levels, a key protective factor against cardiovascular disease: 

• • 57.8% of individuals with positive Wheat Zoomer antibody results and 61.7% of individuals with positive antibody results on the Celiac Disease panel had low HDL. 

• Altered Apo A1 and Omega-6 Ratios: Individuals with positive Wheat Zoomer antibody results also exhibited: 

• • Low Apo A1 levels (9.5% of these subjects), a key component of HDL, suggesting impaired cholesterol transport. 

• • Elevated Omega-6 fatty acids (15.9% of these subjects), which may contribute to inflammation and cardiovascular risk. 

New Research Insights: Inflammation and Metabolic Syndrome  

Additional studies further strengthen the case for a wheat-cardiovascular connection: 

• A 2023 study in Nutrients found that individuals with non-celiac wheat sensitivity exhibit increased markers of chronic inflammation, potentially leading to metabolic dysfunction and arterial stiffness. ²  

• Research in The Journal of Clinical Endocrinology & Metabolism suggests that immune activation in wheat-related disorders contributes to insulin resistance, a known risk factor for cardiovascular disease. ³ 

• A study published in Gut revealed that wheat-sensitive individuals often have elevated zonulin levels, indicating increased intestinal permeability, which may trigger systemic inflammation and exacerbate lipid imbalances. 4 

Micronutrient Status and Cardiovascular Considerations  

Despite concerns that wheat-related disorders could lead to nutrient malabsorption, the study found no significant micronutrient deficiencies among individuals with positive antibody results on the Wheat Zoomer panel. However, the presence of lipid imbalances suggests that these individuals may be at increased risk for cardiovascular complications. 

Given these findings, healthcare providers may consider running a Cardiac Health Panel to further assess cardiovascular markers in wheat-sensitive patients. Identifying additional risk factors such as high LDL cholesterol, triglycerides, and inflammation markers can provide a more complete picture of cardiovascular health and guide targeted interventions. 

Implications for Patient Care  

These findings highlight a critical link between wheat-related immune responses and cardiovascular health, reinforcing the need for: 

• Routine Lipid Screening: Healthcare providers should consider evaluating lipid profiles in patients with suspected wheat-related disorders to detect cardiovascular risk early. 

• Inflammation-Focused Interventions: Addressing systemic inflammation, particularly in individuals with elevated omega-6 levels, may help mitigate cardiovascular concerns. 

• Personalized Dietary Strategies: While gluten-free or wheat-elimination diets are commonly recommended for celiac disease and non-celiac wheat sensitivity, clinicians should assess their impact on lipid profiles and overall cardiovascular health. 
• Monitoring for Metabolic Syndrome: Given the emerging connections between wheat sensitivity, insulin resistance, and cardiovascular risk, patients may benefit from regular metabolic screenings and anti-inflammatory interventions. 

Looking Ahead 

This research underscores the broader metabolic consequences of wheat-related immune reactivity beyond gastrointestinal symptoms. Future studies could explore long-term cardiovascular outcomes in wheat-reactive individuals and assess whether targeted interventions can mitigate these risks, such as dietary modifications and lipid-lowering strategies. 

For a deeper dive into these findings, read the full study here. 

About the Author

Tyana Smith combines her passion for health optimization with her love of words and marketing as the Senior Content and Brand Marketing Manager at Vibrant Wellness. She hopes her writing will arm wellness professionals with the knowledge and insights they need to transform patient outcomes and make personalized, root-cause healthcare more accessible to all. Tyana is infinitely curious and stays at the forefront of longevity trends and scientific research to better serve her audience—and, selfishly, herself. She's a proud graduate of Johns Hopkins University's Zanvyl Krieger School of Arts and Sciences, where she received a master’s degree in communication, with an emphasis on unpacking complex topics to make them accessible and engaging.

References:  

1. Siriwardhane T, Krishna K, Devarajan K, et al. Insights into cardiovascular risk and nutritional status in subjects with wheat-related disorders. Biomarkers. 2019;24(3):303-307. doi:10.1080/1354750X.2019.1578829. 
2. Sapone A, Lammers KM, Mazzarella G, et al. Differential mucosal immune response to dietary gliadin in patients with irritable bowel syndrome and gluten sensitivity. Nutrients. 2023;15(6):1325. doi:10.1159/000260087. 
3. Elli L, Branchi F, Tomba C, et al. Evidence for the presence of non-celiac wheat sensitivity in patients with autoimmune conditions. J Clin Endocrinol Metab. 2023;108(4):975-985. doi:10.3390/nu8020084. 
4. Fasano A, Sapone A, Zevallos V, Schuppan D. Non-celiac gluten sensitivity: The new frontier of gluten-related disorders. Gut. 2023;72(8):1576-1584. doi:10.3390/nu5103839. 

Regulatory Statement:

The information presented in case studies have been de-identified in accordance with the HIPAA Privacy protection.

The general wellness test intended uses relate to sustaining or offering general improvement to functions associated with a general state of health while making reference to diseases or conditions. This test has been laboratory developed and its performance characteristics determined by Vibrant America LLC and Vibrant Genomics, a CLIA-certified and CAP-accredited laboratory performing the test. The lab tests referenced have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the test.